H21 refers to a specific chemical component identified by a unique molecular structure and a complex chemical name. It is commonly designated by the one-letter code X in certain contexts.
Understanding H21 Chemical
The chemical identified as H21 is a intricate organic molecule. Its detailed structure is represented by a very long, systematic chemical name that precisely describes its atomic arrangement and functional groups. Such components are typically found in specialized chemical databases, particularly those related to biological macromolecules.
Key Characteristics of H21
To better understand H21, here are its primary identifiers:
| Identifier Type | Detail |
|---|---|
| One-letter Code | X |
| Molecule Name | 5-chloro-N-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-1H-1,2,4-triazol-3-yl]thiophene-2-carboxamide |
The molecule name, 5-chloro-N-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-1H-1,2,4-triazol-3-yl]thiophene-2-carboxamide, indicates a highly substituted compound featuring several rings, including a chlorothiophene, a fluorophenyl-aminopyridinone, and a triazole group. Its complexity suggests a potential role in biochemical processes or as a synthetic compound for research.
Context and Significance
H21, like many other chemical components, is indexed within comprehensive databases that catalog molecules associated with biological structures. For instance, it is listed in the Chemical Components database of the Protein Data Bank (PDB), which is maintained by organizations like the European Molecular Biology Laboratory - European Bioinformatics Institute (EMBL-EBI). These databases are crucial for:
- Structural Biology: Identifying small molecules bound to proteins or nucleic acids.
- Drug Discovery: Characterizing potential lead compounds or inhibitors.
- Bioinformatics: Providing standardized nomenclature and data for computational analysis.
Such detailed chemical information is essential for researchers to understand molecular interactions, design new experiments, and develop novel therapeutic agents.
